Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia.

Cancer detection and prevention Pub Date : 2000-01-01
G Tramonti, M Ferdeghini, C Donadio, M Norpoth, C Annichiarico, R Bianchi, C Bianchi
{"title":"Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia.","authors":"G Tramonti,&nbsp;M Ferdeghini,&nbsp;C Donadio,&nbsp;M Norpoth,&nbsp;C Annichiarico,&nbsp;R Bianchi,&nbsp;C Bianchi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to evaluate the relationship between renal function and the blood level of some tumor markers that are low molecular weight proteins, that is, tumor-associated trypsin inhibitor (TATI), squamous cells carcinoma antigen (SCC), cytokeratin 19 fragments (CYFRA 21-1), tissue polypeptide antigen (TPA), and M3-specific epitope of tissue polypeptide antigen (TPS). In 41 adult patients without evidence of neoplastic disease, glomerular filtration rate (GFR) and the blood levels of creatinine and of the tumor markers were determined. The decrease in GFR was accompanied by an increase in serum levels of TATI, SCC, CYFRA 21-1, and TPA. The serum level of tumor markers increased particularly when GFR fell below 40 ml/min. On the basis of these results, the renal function must be taken into account for the clinical evaluation of the studied tumor markers.</p>","PeriodicalId":9499,"journal":{"name":"Cancer detection and prevention","volume":"24 1","pages":"86-90"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer detection and prevention","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this study was to evaluate the relationship between renal function and the blood level of some tumor markers that are low molecular weight proteins, that is, tumor-associated trypsin inhibitor (TATI), squamous cells carcinoma antigen (SCC), cytokeratin 19 fragments (CYFRA 21-1), tissue polypeptide antigen (TPA), and M3-specific epitope of tissue polypeptide antigen (TPS). In 41 adult patients without evidence of neoplastic disease, glomerular filtration rate (GFR) and the blood levels of creatinine and of the tumor markers were determined. The decrease in GFR was accompanied by an increase in serum levels of TATI, SCC, CYFRA 21-1, and TPA. The serum level of tumor markers increased particularly when GFR fell below 40 ml/min. On the basis of these results, the renal function must be taken into account for the clinical evaluation of the studied tumor markers.

无肿瘤证据患者的肾功能和5种肿瘤标志物(tti、SCC、CYFRA 21-1、TPA和TPS)的血清浓度
本研究的目的是评估肾功能与一些肿瘤标志物低分子量蛋白的血液水平的关系,即肿瘤相关胰蛋白酶抑制剂(TATI)、鳞状细胞癌抗原(SCC)、细胞角蛋白19片段(CYFRA 21-1)、组织多肽抗原(TPA)和组织多肽抗原m3特异性表位(TPS)。在41例没有肿瘤疾病证据的成年患者中,测定了肾小球滤过率(GFR)、血肌酐水平和肿瘤标志物。GFR的降低伴随着血清中tti、SCC、CYFRA 21-1和TPA水平的升高。血清肿瘤标志物水平升高,特别是当GFR低于40 ml/min时。在这些结果的基础上,临床评价所研究的肿瘤标志物时必须考虑肾功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信